Reliable Product Pipeline for the Biosimilars Witness Significant Growth for the Biosimilars Market

DataM Intelligence's latest market report titled 'Global Biosimilars Market– Size, Share and Forecast' reflects the size, scope, industry dynamics, major firms and future trends in this market.
 
 
Spread the Word
Listed Under

Tag:
* Biosimilars Market

Industry:
* Research

Location:
* Dallas - Texas - US

Subject:
* Earnings

DALLAS - July 16, 2019 - PRLog -- Growing strategic partnerships among the companies for the development of the biosimilars, high growth of the biosimilars across the world, outsourcing of the biosimilars are some of the key trends observed in the global biosimilars market.

Biosimilars Market Dynamics

Low product development costs of the biosimilars (~200-300 million) compared to other biologics products (~700-800 million), less time is taken for the product's approval (~2-3 years less than biologics), growing demand for cost-effective treatment, increasing patent expiries, favourable reimbursements policies for the biosimilars, and reliable product pipeline for the biosimilars are some of the significant factors favouring the growth of the biosimilars.

Biosimilars Market Segmentation

The Biosimilars market by application is segmented into oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, and others.

Oncology biosimilars are one of the largest and the fastest-growing market for biosimilars in the forecasted period. Large numbers of biosimilars are expected to lose its patent during the predicted period while oncology biosimilars are estimated to launch during the same period strengthening the market for oncolytic biosimilars.

Biosimilars Market Geographical Analysis

By geography, Europe dominated the global biosimilars market share in 2017. Regulatory support for the market and raising incidents for cancer in the European region are some of the major factors driving the European market.

The market for biosimilars in the United Kingdom is mature, well established, and easy to enter making it one of the fastest growing regions in the European area.

United States market is not favourable for the biosimilars due to poor access to biosimilars, and conducive regulatory environment and because of which the market is growing at the slower rate but is estimated to increase in the forecasted period. Emerging nations have a high presence of biosimilars and are highly supporting the growth of the market.

Biosimilars Market Report Scope

Segmentation by Therapy Type

• Recombinant Non-Glycosylated Proteins
• Human growth hormone
• Granulocyte colony-stimulating factor
• Interferons
• Insulin
• Recombinant Glycosylated Proteins
• Erythropoietin
• Monoclonal antibodies
• Follitropin

Segmentation by End User

• Hospitals
• Retail Pharmacies
• The report also covers the key factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product
• Benchmarking, and company profiles.

To know more information about the report - https://www.datamintelligence.com/research-report/biosimilars-market

Contact
Sai Kiran
***@datamintelligence.com
+1 877 441 4866
End
Email:***@datamintelligence.com
Posted By:***@datamintelligence.com Email Verified
Tags:Biosimilars Market
Industry:Research
Location:Dallas - Texas - United States
Subject:Earnings
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Data M Intelligence News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share